$DCGO
DocGo Inc. Stock $dcgo

$dcgo Overview Financials Valuation SEC Filings Company Website

2022 Q4 Form 10-Q Financial Statement

#000121390022070146 Filed on November 08, 2022

Income Statement

Concept	2022 Q4	2022 Q3	2021 Q4
Revenue	$108.8M	$104.3M	$318.7M
YoY Change	-65.87%	21.53%
Cost Of Revenue	$66.38M	$71.25M
YoY Change
Gross Profit	$42.41M	$33.07M
YoY Change
Gross Profit Margin	38.98%	31.7%
Selling, General & Admin	$35.13M	$22.28M	$73.92M
YoY Change	-52.48%	6264.83%
% of Gross Profit	82.82%	67.37%
Research & Development	$1.722M	$1.373M
YoY Change		60.67%
% of Gross Profit	4.06%	4.15%
Depreciation & Amortization	$3.312M	$1.151M	$7.072M
YoY Change	-53.17%	92.38%
% of Gross Profit	7.81%	3.48%
Operating Expenses	$40.16M	$100.1M	$302.4M
YoY Change	-86.72%	28505.92%	177773.41%
Operating Profit	$2.250M	$4.199M
YoY Change		176.4%
Interest Expense	$365.2K	-$1.404M	$5.200M
YoY Change	-92.98%	-257.79%	25897.5%
% of Operating Profit	16.23%	-33.44%
Other Income/Expense, Net	-$1.030M	$30.90K	-$1.230M
YoY Change	-16.27%
Pretax Income	-$1.977M	$2.868M	$20.30M
YoY Change	-109.74%	431.19%	-13635.6%
Income Tax	-$9.125M	$401.9K	$615.7K
% Of Pretax Income		14.01%	3.03%
Net Earnings	$8.065M	$2.466M	$24.25M
YoY Change	-66.75%	356.76%	-16267.98%
Net Earnings / Revenue	7.41%	2.36%	7.61%
Basic Earnings Per Share		$0.03
Diluted Earnings Per Share	$0.08	$0.03	$255.7K
COMMON SHARES
Basic Shares Outstanding	102.8M shares	98.96M shares
Diluted Shares Outstanding		107.4M shares

Balance Sheet

Concept	2022 Q4	2022 Q3	2021 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$157.3M	$169.6M
YoY Change		282564.58%
Cash & Equivalents	$157.3M	$169.6M	$175.5M
Short-Term Investments
Other Short-Term Assets	$10.75M	$2.394M
YoY Change		941.01%
Inventory
Prepaid Expenses
Receivables	$103.0M	$80.00M
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$271.1M	$252.0M	$256.0M
YoY Change	5.88%	86794.08%	24284.05%
LONG-TERM ASSETS
Property, Plant & Equipment	$21.26M	$17.58M	$12.73M
YoY Change	66.94%
Goodwill	$38.90M	$34.53M	$8.687M
YoY Change	347.8%
Intangibles	$22.97M	$20.65M	$10.68M
YoY Change	115.11%
Long-Term Investments	$598.0K	$712.7K	$589.1K
YoY Change	1.51%	-99.38%
Other Assets	$3.625M	$3.095M	$3.811M
YoY Change	-4.87%
Total Long-Term Assets	$122.2M	$103.9M	$53.57M
YoY Change	128.11%	-9.63%	-53.43%
TOTAL ASSETS
Total Short-Term Assets	$271.1M	$252.0M	$256.0M
Total Long-Term Assets	$122.2M	$103.9M	$53.57M
Total Assets	$393.3M	$355.9M	$309.6M
YoY Change	27.03%	208.72%	166.74%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$21.58M	$12.15M	$15.83M
YoY Change	36.31%	7495.84%	158239.7%
Accrued Expenses	$31.57M	$38.56M	$35.11M
YoY Change	-10.08%	54982.96%	50058.4%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$1.026M
YoY Change
Long-Term Debt Due	$664.9K	$680.7K
YoY Change
Total Short-Term Liabilities	$100.2M	$71.14M	$57.88M
YoY Change	73.06%	21457.11%	36072.45%
LONG-TERM LIABILITIES
Long-Term Debt	$7.151M	$7.543M
YoY Change
Other Long-Term Liabilities	$7.041M	$6.406M
YoY Change		-49.24%
Total Long-Term Liabilities	$14.19M	$13.95M
YoY Change		10.53%
TOTAL LIABILITIES
Total Short-Term Liabilities	$100.2M	$71.14M	$57.88M
Total Long-Term Liabilities	$14.19M	$13.95M
Total Liabilities	$114.4M	$85.09M	$82.55M
YoY Change	38.53%	557.05%	1874.78%
SHAREHOLDERS EQUITY
Retained Earnings	-$28.97M	-$37.04M	-$63.56M
YoY Change	-54.42%
Common Stock	$10.24K	$10.78K	$10.01K
YoY Change	2.28%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$273.2M	$264.2M	$219.6M
YoY Change
Total Liabilities & Shareholders Equity	$393.3M	$355.9M	$309.6M
YoY Change	27.03%	208.72%	166.74%

Cashflow Statement

Concept	2022 Q4	2022 Q3	2021 Q4
OPERATING ACTIVITIES
Net Income	$8.065M	$2.466M	$24.25M
YoY Change	-66.75%	356.76%	-16267.98%
Depreciation, Depletion And Amortization	$3.312M	$1.151M	$7.072M
YoY Change	-53.17%	92.38%
Cash From Operating Activities	-$8.738M	$7.421M	-$1.087M
YoY Change	703.52%	-4222.54%	338.6%
INVESTING ACTIVITIES
Capital Expenditures	$1.547M	-$1.993M	-$6.708M
YoY Change	-123.06%
Acquisitions
YoY Change
Other Investing Activities	$893.2K	-$33.84M	-$1.921M
YoY Change	-146.49%	-338533.7%	-98.33%
Cash From Investing Activities	-$654.0K	-$35.84M	-$8.629M
YoY Change	-92.42%	-358458.8%	-92.5%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net			$178.7M
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-6.866M	-436.4K	155.2M
YoY Change	-104.42%		33.65%
NET CHANGE
Cash From Operating Activities	-8.738M	7.421M	-1.087M
Cash From Investing Activities	-654.0K	-35.84M	-8.629M
Cash From Financing Activities	-6.866M	-436.4K	155.2M
Net Change In Cash	-16.26M	-28.85M	145.5M
YoY Change	-111.17%	16871.61%	16461.73%
FREE CASH FLOW
Cash From Operating Activities	-$8.738M	$7.421M	-$1.087M
Capital Expenditures	$1.547M	-$1.993M	-$6.708M
Free Cash Flow	-$10.28M	$9.413M	$5.621M
YoY Change	-282.98%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	12733889	usd
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2022-09-30
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	001-39618
	dei	Entity Registrant Name EntityRegistrantName	DocGo Inc.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	85-2515483
	dei	Entity Address Address Line1 EntityAddressAddressLine1	35 West 35th Street
	dei	Entity Address Address Line2 EntityAddressAddressLine2	Floor 6
	dei	Entity Address City Or Town EntityAddressCityOrTown	New York
	dei	Entity Address State Or Province EntityAddressStateOrProvince	NY
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	10001
	dei	City Area Code CityAreaCode	(844)
	dei	Local Phone Number LocalPhoneNumber	443-6246
	dei	Security12b Title Security12bTitle	Common Stock, par value $0.0001 per share
	dei	Trading Symbol TradingSymbol	DCGO
	dei	Security Exchange Name SecurityExchangeName	NASDAQ
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2022Q3	us-gaap	Assets Assets	355920210	usd
CY2022Q3	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	20647790	usd
CY2021Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	10678049	usd
CY2022Q3	us-gaap	Goodwill Goodwill	34533363	usd
CY2021Q4	us-gaap	Goodwill Goodwill	8686966	usd
CY2022Q3	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	9753575	usd
CY2021Q4	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	3568509	usd
CY2022Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	8185547	usd
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	4195682	usd
CY2022Q3	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	9421196	usd
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
	dei	Entity Shell Company EntityShellCompany	false
CY2022Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	102826671	shares
CY2022Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	169598749	usd
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	175537221	usd
CY2022Q3	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	7376957	usd
CY2021Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	7377389	usd
CY2022Q3	us-gaap	Receivables Net Current ReceivablesNetCurrent	79999764	usd
CY2021Q4	us-gaap	Receivables Net Current ReceivablesNetCurrent	78383614	usd
CY2022Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	2394324	usd
CY2021Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	2111656	usd
CY2022Q3	us-gaap	Assets Current AssetsCurrent	251992837	usd
CY2021Q4	us-gaap	Assets Current AssetsCurrent	256032491	usd
CY2022Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	17577830	usd
CY2021Q4	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	9307113	usd
CY2022Q3	us-gaap	Equity Method Investments EquityMethodInvestments	712718	usd
CY2021Q4	us-gaap	Equity Method Investments EquityMethodInvestments	589058	usd
CY2022Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	3095354	usd
CY2021Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	3810895	usd
CY2021Q4	us-gaap	Assets Assets	309602652	usd
CY2022Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	12153337	usd
CY2021Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	15833970	usd
CY2022Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	38558074	usd
CY2021Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	35110877	usd
CY2022Q3	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	1025881	usd
CY2021Q4	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	25881	usd
CY2022Q3	us-gaap	Notes Payable Current NotesPayableCurrent	680703	usd
CY2021Q4	us-gaap	Notes Payable Current NotesPayableCurrent	600449	usd
CY2022Q3	us-gaap	Due To Related Parties Current DueToRelatedPartiesCurrent	9802238	usd
CY2021Q4	us-gaap	Due To Related Parties Current DueToRelatedPartiesCurrent	1571419	usd
CY2022Q3	us-gaap	Business Combination Contingent Consideration Liability Current BusinessCombinationContingentConsiderationLiabilityCurrent	4000000	usd
CY2022Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	2059278	usd
CY2021Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	1461335	usd
CY2022Q3	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	2858968	usd
CY2021Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	3271990	usd
CY2022Q3	us-gaap	Liabilities Current LiabilitiesCurrent	71138479	usd
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	57875921	usd
CY2022Q3	us-gaap	Convertible Long Term Notes Payable ConvertibleLongTermNotesPayable	1456105	usd
CY2021Q4	us-gaap	Convertible Long Term Notes Payable ConvertibleLongTermNotesPayable	1302839	usd
CY2022Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	6406246	usd
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	2980946	usd
CY2022Q3	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	6086521	usd
CY2021Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	6867420	usd
CY2021Q4	us-gaap	Derivative Liabilities DerivativeLiabilities	13518502	usd
CY2022Q3	us-gaap	Liabilities Liabilities	85087351	usd
CY2021Q4	us-gaap	Liabilities Liabilities	82545628	usd
CY2022Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	500000000	shares
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	500000000	shares
CY2022Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	102824878	shares
CY2022Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	102824878	shares
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	100133953	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	100133953	shares
CY2022Q3	us-gaap	Common Stock Value CommonStockValue	10778	usd
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	10013	usd
CY2022Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	301522213	usd
CY2021Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	283161216	usd
CY2022Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-37036937	usd
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-63556714	usd
CY2022Q3	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-276213	usd
CY2021Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-32501	usd
CY2022Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	355920210	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	264219841	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	219582014	usd
CY2022Q3	us-gaap	Minority Interest MinorityInterest	6613018	usd
CY2021Q4	us-gaap	Minority Interest MinorityInterest	7475010	usd
CY2022Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	270832859	usd
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	227057024	usd
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	309602652	usd
CY2022Q3	us-gaap	Revenues Revenues	104319894	usd
CY2021Q3	us-gaap	Revenues Revenues	85838988	usd
	us-gaap	Revenues Revenues	331730750	usd
	us-gaap	Revenues Revenues	197394379	usd
CY2022Q3	dcgo	Cost Of Revenues CostOfRevenues	71254838	usd
CY2021Q3	dcgo	Cost Of Revenues CostOfRevenues	60025728	usd
	dcgo	Cost Of Revenues CostOfRevenues	219418873	usd
	dcgo	Cost Of Revenues CostOfRevenues	137080202	usd
CY2022Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	22186036	usd
CY2021Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	19612243	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	70684270	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	47239204	usd
CY2022Q3	us-gaap	Depreciation And Amortization DepreciationAndAmortization	3014864	usd
CY2021Q3	us-gaap	Depreciation And Amortization DepreciationAndAmortization	2019576	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	7253656	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	5514303	usd
CY2022Q3	us-gaap	Legal Fees LegalFees	2200964	usd
CY2021Q3	us-gaap	Legal Fees LegalFees	813204	usd
	us-gaap	Legal Fees LegalFees	6610223	usd
	us-gaap	Legal Fees LegalFees	2646573	usd
CY2022Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1373146	usd
CY2021Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	854618	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	3663299	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1980899	usd
CY2022Q3	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	90856	usd
CY2021Q3	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	994401	usd
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	2348917	usd
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	3029182	usd
CY2022Q3	us-gaap	Operating Expenses OperatingExpenses	100120704	usd
CY2021Q3	us-gaap	Operating Expenses OperatingExpenses	84319770	usd
	us-gaap	Operating Expenses OperatingExpenses	309979238	usd
	us-gaap	Operating Expenses OperatingExpenses	197490363	usd
CY2022Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	4199190	usd
CY2021Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	1519218	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	21751512	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-95984	usd
CY2022Q3	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	334221	usd
CY2021Q3	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-255711	usd
	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	296891	usd
	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-500849	usd
CY2022Q3	us-gaap	Unrealized Gain Loss On Derivatives And Commodity Contracts UnrealizedGainLossOnDerivativesAndCommodityContracts	-1831947	usd
	us-gaap	Unrealized Gain Loss On Derivatives And Commodity Contracts UnrealizedGainLossOnDerivativesAndCommodityContracts	1137070	usd
CY2022Q3	dcgo	Income Loss From Equity Methods Investments IncomeLossFromEquityMethodsInvestments	93371	usd
	dcgo	Income Loss From Equity Methods Investments IncomeLossFromEquityMethodsInvestments	99840	usd
	us-gaap	Gain Loss On Investments GainLossOnInvestments	1388273	usd
CY2021Q3	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	142667	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	142667	usd
CY2022Q3	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	-1330788	usd
CY2022Q3	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	42667	usd
	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	42667	usd
	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	-27730	usd
CY2022Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	30900	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	42288	usd
CY2021Q3	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	-113044	usd
	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	3007029	usd
	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	-385912	usd
CY2022Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	2868402	usd
CY2021Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	1406174	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	24758541	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-481896	usd
CY2022Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	401916	usd
CY2021Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	604608	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1163755	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	613531	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	2466486	usd
CY2021Q3	us-gaap	Net Income Loss NetIncomeLoss	801566	usd
	us-gaap	Net Income Loss NetIncomeLoss	23594786	usd
	us-gaap	Net Income Loss NetIncomeLoss	-1095427	usd
CY2022Q3	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-687944	usd
CY2021Q3	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-2705954	usd
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-2924992	usd
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-1278363	usd
CY2022Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	3154430	usd
CY2021Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	3507520	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	26519778	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	182936	usd
CY2022Q3	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	248283	usd
CY2021Q3	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	69193	usd
	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	252854	usd
	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	171846	usd
CY2022Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	3402713	usd
CY2021Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	3576713	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	26772632	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	354782	usd
CY2022Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.03
CY2021Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.06
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.26
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0
CY2022Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	98960538	shares
CY2021Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	58388866	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	100725697	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	58388866	shares
CY2022Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.03
CY2021Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.04
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.24
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0
CY2022Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	107403135	shares
CY2021Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	83701783	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	109168293	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	83701783	shares
CY2020Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	66947041	usd
CY2021Q1	us-gaap	Stock Issued During Period Value Conversion Of Units StockIssuedDuringPeriodValueConversionOfUnits	7649	usd
CY2021Q1	dcgo	Stock Issued Effect Of Reverse Acquisition StockIssuedEffectOfReverseAcquisition	66954690	usd
CY2022Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	270832859	usd
CY2021Q1	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	17	usd
CY2021Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	391534	usd
CY2021Q1	dcgo	Noncontrolling Interest Contribution NoncontrollingInterestContribution	333025	usd
CY2021Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	7998	usd
CY2021Q1	us-gaap	Profit Loss ProfitLoss	-320632	usd
CY2021Q1	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-1678364	usd
CY2021Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	65688268	usd
CY2021Q2	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	370000	usd
CY2021Q2	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	94655	usd
CY2021Q2	us-gaap	Profit Loss ProfitLoss	1748223	usd
CY2021Q2	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-1646216	usd
CY2021Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	66254930	usd
CY2021Q3	dcgo	Stock Issued During Period Value Uk Ltd Shares Purchase StockIssuedDuringPeriodValueUKLtdSharesPurchase	-523717	usd
CY2021Q3	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	463046	usd
CY2021Q3	dcgo	Stock Issued During Period Value Fees Associated With Equity Raise StockIssuedDuringPeriodValueFeesAssociatedWithEquityRaise	-1398	usd
CY2021Q3	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	69193	usd
CY2021Q3	us-gaap	Profit Loss ProfitLoss	-2705954	usd
CY2021Q3	dcgo	Net Loss Attributable To Stockholders Of Ambulnz Inc And Subsidiaries NetLossAttributableToStockholdersOfAmbulnzIncAndSubsidiaries	3507520	usd
CY2021Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	67063620	usd
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	227057024	usd
CY2022Q1	dcgo	Stock Issued During Period Value Exercise Of Stock Options StockIssuedDuringPeriodValueExerciseOfStockOptions	374344	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	1422937	usd
CY2022Q1	dcgo	Stock Issued During Period Value Equity Cost StockIssuedDuringPeriodValueEquityCost	-19570	usd
CY2022Q1	dcgo	Noncontrolling Interest Contribution NoncontrollingInterestContribution	2063000	usd
CY2022Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-5863	usd
CY2022Q1	us-gaap	Profit Loss ProfitLoss	-1257257	usd
CY2022Q1	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	10629694	usd
CY2022Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	240264309	usd
CY2022Q2	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	497899	usd
CY2022Q2	dcgo	Stock Issued During Period Value Exercise Of Stock Options StockIssuedDuringPeriodValueExerciseOfStockOptions	779066	usd
CY2022Q2	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	1999619	usd
CY2022Q2	dcgo	Stock Issued During Period Value Uk Ltd Restricted Stock StockIssuedDuringPeriodValueUKLtdRestrictedStock	82305	usd
CY2022Q2	us-gaap	Profit Loss ProfitLoss	-979791	usd
CY2022Q2	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	10434	usd
CY2022Q2	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	12735653	usd
CY2022Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	254393696	usd
CY2022Q3	dcgo	Stock Issued During Period Value Exercise Of Stock Options StockIssuedDuringPeriodValueExerciseOfStockOptions	728503	usd
CY2022Q3	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	-319	usd
CY2022Q3	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	1015660	usd
CY2022Q3	dcgo	Stock Issued During Period Value Uk Ltd Restricted Stock StockIssuedDuringPeriodValueUKLtdRestrictedStock	95543	usd
CY2022Q3	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	12381573	usd
CY2022Q3	us-gaap	Profit Loss ProfitLoss	-687944	usd
CY2022Q3	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-248283	usd
CY2022Q3	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	3154430	usd
	us-gaap	Net Income Loss NetIncomeLoss	23594786	usd
	us-gaap	Net Income Loss NetIncomeLoss	-1095427	usd
	us-gaap	Depreciation Nonproduction DepreciationNonproduction	2592244	usd
	us-gaap	Depreciation Nonproduction DepreciationNonproduction	1697380	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	2269423	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1432983	usd
	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	2391989	usd
	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	2383940	usd
	us-gaap	Gain Loss On Sale Of Other Assets GainLossOnSaleOfOtherAssets	42667	usd
	us-gaap	Gain Loss On Sale Of Other Assets GainLossOnSaleOfOtherAssets	-27730	usd
	us-gaap	Gains Losses On Restructuring Of Debt GainsLossesOnRestructuringOfDebt	142667	usd
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	99840	usd
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	2702979	usd
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	2152470	usd
	us-gaap	Employee Benefits And Share Based Compensation EmployeeBenefitsAndShareBasedCompensation	4616056	usd
	us-gaap	Employee Benefits And Share Based Compensation EmployeeBenefitsAndShareBasedCompensation	1224580	usd
	us-gaap	Gain Loss On Termination Of Lease GainLossOnTerminationOfLease	1388273	usd
	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives	1137070	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-2894650	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	28794602	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	282668	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	4531411	usd
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-882432	usd
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	1786407	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-3983383	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	9422628	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	2596887	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	24861804	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	37607545	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	6853001	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1994161	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	2824916	usd
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	1956434	usd
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	1571959	usd
	us-gaap	Other Payments To Acquire Businesses OtherPaymentsToAcquireBusinesses	33843373	usd
	us-gaap	Other Payments To Acquire Businesses OtherPaymentsToAcquireBusinesses	56496	usd
	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	6000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-37793968	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-4447371	usd
	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	1000000	usd
	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	8000000	usd
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	585711	usd
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	374456	usd
	dcgo	Due To Seller DueToSeller	1007800	usd
	us-gaap	Proceeds From Minority Shareholders ProceedsFromMinorityShareholders	2063000	usd
	us-gaap	Proceeds From Minority Shareholders ProceedsFromMinorityShareholders	333025	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	1880568	usd
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	497759	usd
	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	19570	usd
	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	2146857	usd
	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	1830823	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	685871	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	6127746	usd
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	-252854	usd
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	171846	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	246594	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	8705222	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	179105730	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	34457273	usd
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	179352324	usd
CY2021Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	43162495	usd
	dcgo	Cash Paid For Interest CashPaidForInterest	102203	usd
	dcgo	Cash Paid For Interest CashPaidForInterest	39637	usd
	dcgo	Cash Paid For Interest On Finance Lease Liabilities CashPaidForInterestOnFinanceLeaseLiabilities	434580	usd
	dcgo	Cash Paid For Interest On Finance Lease Liabilities CashPaidForInterestOnFinanceLeaseLiabilities	381937	usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	917445	usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	613531	usd
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	4094731	usd
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	3569276	usd
	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	819231	usd
	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	271194	usd
	dcgo	Acquisition Of Remainings AcquisitionOfRemainings	0.20	pure
	dcgo	Acquisition Of Remainings AcquisitionOfRemainings	0.20	pure
	us-gaap	Stock Issued1 StockIssued1	228518	usd
	dcgo	Gain From Ppp Loan Forgiveness GainFromPPPLoanForgiveness	142667	usd
	dcgo	Reconciliation Of Cash ReconciliationOfCash	169598749	usd
	dcgo	Reconciliation Of Cash ReconciliationOfCash	39550926	usd
	dcgo	Reconcillation Of Restricted Cash ReconcillationOfRestrictedCash	9753575	usd
	dcgo	Reconcillation Of Restricted Cash ReconcillationOfRestrictedCash	3611569	usd
	dcgo	Total Cash And Restricted Cash Shown In Statement Of Cash Flows TotalCashAndRestrictedCashShownInStatementOfCashFlows	179352324	usd
	dcgo	Total Cash And Restricted Cash Shown In Statement Of Cash Flows TotalCashAndRestrictedCashShownInStatementOfCashFlows	43162495	usd
	dcgo	Net Proceeds NetProceeds	158000000	usd
	dcgo	Cash Held Trust Account CashHeldTrustAccount	43400000	usd
	us-gaap	Asset Acquisition Consideration Transferred Transaction Cost AssetAcquisitionConsiderationTransferredTransactionCost	9600000	usd
	dcgo	Revenue Loss RevenueLoss	321079	usd
CY2021Q3	dcgo	Total Current Assets TotalCurrentAssets	220081	usd
CY2021Q3	dcgo	Total Stockholders Deficit TotalStockholdersDeficit	30914	usd
	us-gaap	Use Of Estimates UseOfEstimates	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Use of Estimates</i></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The preparation of financial statements requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities and expenses and the disclosure of contingent assets and liabilities in its financial statements and the reported amounts of expenses during the reporting period. The most significant estimates in the Company’s financial statements relate to revenue recognition related to the allowance for doubtful accounts, stock based compensation, calculations related to the incremental borrowing rate for the Company’s lease agreements, estimates related to ongoing lease terms, software development costs, impairment of long-lived assets, goodwill and indefinite-lived intangible assets, business combinations, reserve for losses within the Company’s insurance deductibles, income taxes, and deferred income tax. These estimates and assumptions are based on current facts, historical experience and various other factors believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the recording of expenses that are not readily apparent from other sources.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Actual results may differ materially and adversely from these estimates. To the extent there are material differences between the estimates and actual results, the Company’s future results of operations will be affected.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p>
	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Concentration of Credit Risk and Off-Balance Sheet Risk</i></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company is potentially subject to concentration of credit risk with respect to its cash, cash equivalents and restricted cash, which the Company attempts to minimize by maintaining cash, cash equivalents and restricted cash with institutions of sound financial quality. At times, cash balances may exceed limits federally insured by the Federal Deposit Insurance Corporation (“FDIC”). The Company believes it is not exposed to significant credit risk due to the financial strength of the depository institutions in which the funds are held. The Company has no financial instruments with off-balance sheet risk of loss.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p>
	dcgo	Number Of Customers NumberOfCustomers	1	pure
	dcgo	Number Of Customers NumberOfCustomers	1	pure
CY2022Q3	us-gaap	Other Cash Equivalents At Carrying Value OtherCashEquivalentsAtCarryingValue	433000	usd
CY2021Q4	us-gaap	Other Cash Equivalents At Carrying Value OtherCashEquivalentsAtCarryingValue	913000	usd
CY2022Q3	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	28166490	usd
CY2021Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	20881155	usd
CY2022Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	10588660	usd
CY2021Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	8147266	usd
CY2022Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	17577830	usd
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	12733889	usd
CY2022Q3	us-gaap	Depreciation Depreciation	1150806	usd
CY2021Q3	us-gaap	Depreciation Depreciation	598188	usd
	us-gaap	Depreciation Depreciation	2592244	usd
	us-gaap	Depreciation Depreciation	1697380	usd
	us-gaap	Business Combination Consideration Transferred Other1 BusinessCombinationConsiderationTransferredOther1	34136041	usd
CY2022Q3	us-gaap	Due To Affiliate Current DueToAffiliateCurrent	6000000	usd
	us-gaap	Business Combination Consideration Transferred1 BusinessCombinationConsiderationTransferred1	4000000	usd
CY2022Q3	us-gaap	Assets Held In Trust Current AssetsHeldInTrustCurrent	1333333	usd
CY2022Q3	us-gaap	Business Combination Contingent Consideration Asset BusinessCombinationContingentConsiderationAsset	45469374	usd
CY2022Q3	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Financial Assets BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancialAssets	1925051	usd
CY2022Q3	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Assets Receivables BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables	3975160	usd
CY2022Q3	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Assets Other BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther	166891	usd
CY2022Q3	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Equipment BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedEquipment	4580126	usd
CY2022Q3	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Intangible Assets Other Than Goodwill BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill	10306550	usd
CY2022Q3	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Assets BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets	20953778	usd
CY2022Q3	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Liabilities Accounts Payable BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable	182150	usd
CY2022Q3	us-gaap	Due To Affiliate Noncurrent DueToAffiliateNoncurrent	299050	usd
CY2022Q3	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Liabilities Other BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther	849601	usd
CY2022Q3	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Net BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet	1330801	usd
CY2022Q3	us-gaap	Goodwill Gross GoodwillGross	25846397	usd
CY2022Q3	us-gaap	Business Combination Recognized Identifiable Assets Acquired Goodwill And Liabilities Assumed Less Noncontrolling Interest BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest	45469374	usd
CY2021Q4	dcgo	Goodwill Amount GoodwillAmount	8686966	usd
	us-gaap	Goodwill Transfers GoodwillTransfers	25846397	usd
CY2022Q3	dcgo	Goodwill Amount GoodwillAmount	34533363	usd
CY2022Q3	us-gaap	Property Plant And Equipment Other PropertyPlantAndEquipmentOther	14731842	usd
	us-gaap	Property Plant And Equipment Additions PropertyPlantAndEquipmentAdditions	12239165	usd
CY2022Q3	us-gaap	Property Plant And Equipment Other Accumulated Depreciation PropertyPlantAndEquipmentOtherAccumulatedDepreciation	6323217	usd
CY2022Q3	us-gaap	Property Plant And Equipment Other Net PropertyPlantAndEquipmentOtherNet	20647790	usd
CY2021Q4	us-gaap	Property Plant And Equipment Other PropertyPlantAndEquipmentOther	10674106	usd
CY2021	us-gaap	Property Plant And Equipment Additions PropertyPlantAndEquipmentAdditions	4057736	usd
CY2021Q4	us-gaap	Property Plant And Equipment Other Accumulated Depreciation PropertyPlantAndEquipmentOtherAccumulatedDepreciation	4053793	usd
CY2021Q4	us-gaap	Property Plant And Equipment Other Net PropertyPlantAndEquipmentOtherNet	10678049	usd
CY2022Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	990345	usd
CY2021Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	552999	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	2269423	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1432983	usd
	dcgo	Amortization Expense AmortizationExpense	P5Y
CY2022Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Rolling Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextRollingTwelveMonths	680930	usd
CY2022Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	2078406	usd
CY2022Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	1510563	usd
CY2022Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	1460965	usd
CY2022Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	1094588	usd
CY2022Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	4934074	usd
CY2022Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	11759526	usd
CY2022Q3	us-gaap	Fair Value Net Asset Liability FairValueNetAssetLiability	2269423	usd
CY2021Q3	us-gaap	Fair Value Net Asset Liability FairValueNetAssetLiability	1432983	usd
CY2021Q4	us-gaap	Fair Value Net Asset Liability FairValueNetAssetLiability	1845193	usd
CY2022Q3	us-gaap	Accrued Bonuses Current And Noncurrent AccruedBonusesCurrentAndNoncurrent	496660	usd
CY2021Q4	us-gaap	Accrued Bonuses Current And Noncurrent AccruedBonusesCurrentAndNoncurrent	7260456	usd
CY2022Q3	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	1363138	usd
CY2021Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	4885539	usd
CY2022Q3	us-gaap	Accrued Payroll Taxes Current AccruedPayrollTaxesCurrent	7068616	usd
CY2021Q4	us-gaap	Accrued Payroll Taxes Current AccruedPayrollTaxesCurrent	3539301	usd
CY2021Q4	dcgo	Medicare Advance MedicareAdvance	975415	usd
CY2022Q3	dcgo	Fica Medicare Liability FICAMedicareLiability	759232	usd
CY2021Q4	dcgo	Fica Medicare Liability FICAMedicareLiability	739629	usd
CY2022Q3	dcgo	Accrued General Expenses AccruedGeneralExpenses	7393906	usd
CY2021Q4	dcgo	Accrued General Expenses AccruedGeneralExpenses	3497418	usd
CY2022Q3	dcgo	Accrued Subcontractors AccruedSubcontractors	11259341	usd
CY2021Q4	dcgo	Accrued Subcontractors AccruedSubcontractors	9564833	usd
CY2022Q3	dcgo	Accrued Fuel And Maintenance AccruedFuelAndMaintenance	310064	usd
CY2021Q4	dcgo	Accrued Fuel And Maintenance AccruedFuelAndMaintenance	450842	usd
CY2022Q3	us-gaap	Accrued Employee Benefits Current AccruedEmployeeBenefitsCurrent	5465030	usd
CY2021Q4	us-gaap	Accrued Employee Benefits Current AccruedEmployeeBenefitsCurrent	2259571	usd
CY2022Q3	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	12259	usd
CY2021Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	736021	usd
CY2022Q3	us-gaap	Accrued Professional Fees Current And Noncurrent AccruedProfessionalFeesCurrentAndNoncurrent	2447997	usd
CY2021Q4	us-gaap	Accrued Professional Fees Current And Noncurrent AccruedProfessionalFeesCurrentAndNoncurrent	1143629	usd
CY2022Q3	us-gaap	Accrued Liabilities And Other Liabilities AccruedLiabilitiesAndOtherLiabilities	1840420	usd
CY2022Q3	dcgo	Credit Card Payable CreditCardPayable	141411	usd
CY2021Q4	dcgo	Credit Card Payable CreditCardPayable	58223	usd
CY2022Q3	us-gaap	Accrued Liabilities Current And Noncurrent AccruedLiabilitiesCurrentAndNoncurrent	38558074	usd
CY2021Q4	us-gaap	Accrued Liabilities Current And Noncurrent AccruedLiabilitiesCurrentAndNoncurrent	35110877	usd
CY2021Q4	us-gaap	Advances To Affiliate AdvancesToAffiliate	12000000	usd
CY2021Q4	dcgo	Revolving Advances Description RevolvingAdvancesDescription	Each Revolving Advance shall bear interest at a per annum rate equal to the Wall Street Journal Prime Rate (6.25% at September 30, 2022), as the same may change from time to time, plus one percent (1.00%), but in no event less than five percent (5.00%) per annum, calculated on the basis of a 360-day year for the actual number of days in the applicable period.
CY2021Q4	us-gaap	Debtor In Possession Financing Fee On Unused Borrowings DebtorInPossessionFinancingFeeOnUnusedBorrowings	0.005	pure
CY2021Q4	us-gaap	Financing Receivable Revolving FinancingReceivableRevolving	12	usd
CY2022Q1	us-gaap	Proceeds From Short Term Capital Lease Obligations ProceedsFromShortTermCapitalLeaseObligations	1000000	usd
	us-gaap	Line Of Credit Facility Average Outstanding Amount LineOfCreditFacilityAverageOutstandingAmount	1000000	usd
CY2022Q3	dcgo	Installment Amount InstallmentAmount	64855	usd
CY2022Q3	us-gaap	Other Loans Payable OtherLoansPayable	2136808	usd
CY2021Q4	us-gaap	Other Loans Payable OtherLoansPayable	1903288	usd
CY2022Q3	us-gaap	Notes Payable NotesPayable	2136808	usd
CY2021Q4	us-gaap	Notes Payable NotesPayable	1903288	usd
CY2022Q3	us-gaap	Notes And Loans Payable Current NotesAndLoansPayableCurrent	680703	usd
CY2021Q4	us-gaap	Notes And Loans Payable Current NotesAndLoansPayableCurrent	600449	usd
CY2022Q3	us-gaap	Long Term Notes Payable LongTermNotesPayable	1456105	usd
CY2021Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable	1302839	usd
	us-gaap	Interest Expense Debt InterestExpenseDebt	69804	usd
CY2021	us-gaap	Interest Expense Debt InterestExpenseDebt	61324	usd
CY2022Q3	us-gaap	Finance Lease Liability Payments Due In Next Rolling Twelve Months FinanceLeaseLiabilityPaymentsDueInNextRollingTwelveMonths	137959	usd
CY2022Q3	us-gaap	Finance Lease Liability Payments Due Year Two FinanceLeaseLiabilityPaymentsDueYearTwo	582722	usd
CY2022Q3	us-gaap	Finance Lease Liability Payments Due In Rolling Year Three FinanceLeaseLiabilityPaymentsDueInRollingYearThree	446812	usd
CY2022Q3	us-gaap	Finance Lease Liability Payments Due In Rolling Year Four FinanceLeaseLiabilityPaymentsDueInRollingYearFour	386785	usd
CY2022Q3	us-gaap	Finance Lease Liability Payments Due In Rolling Year Five FinanceLeaseLiabilityPaymentsDueInRollingYearFive	311769	usd
CY2022Q3	us-gaap	Finance Lease Liability Payments Due In Rolling After Year Five FinanceLeaseLiabilityPaymentsDueInRollingAfterYearFive	270761	usd
CY2022Q3	us-gaap	Finance Lease Liability Payments Due FinanceLeaseLiabilityPaymentsDue	2136808	usd
CY2022Q3	us-gaap	Long Term Debt Current LongTermDebtCurrent	680703	usd
CY2022Q3	us-gaap	Other Notes Payable OtherNotesPayable	1456105	usd
CY2022Q3	us-gaap	Disposal Group Including Discontinued Operation Revenue DisposalGroupIncludingDiscontinuedOperationRevenue	104319894	usd
CY2022Q3	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	4199190	usd
CY2022Q3	dcgo	Total Assets TotalAssets	355920210	usd
CY2022Q3	us-gaap	Cost Depreciation Amortization And Depletion CostDepreciationAmortizationAndDepletion	3014864	usd
CY2022Q3	dcgo	Stock Compensation StockCompensation	1111203	usd
CY2022Q3	us-gaap	Noncurrent Assets NoncurrentAssets	72758983	usd
CY2021Q3	us-gaap	Disposal Group Including Discontinued Operation Revenue DisposalGroupIncludingDiscontinuedOperationRevenue	85838988	usd
CY2021Q3	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	1519218	usd
CY2021Q3	dcgo	Total Assets TotalAssets	144078865	usd
CY2021Q3	us-gaap	Cost Depreciation Amortization And Depletion CostDepreciationAmortizationAndDepletion	2019576	usd
CY2021Q3	dcgo	Stock Compensation StockCompensation	463046	usd
CY2021Q3	us-gaap	Noncurrent Assets NoncurrentAssets	27894236	usd
	us-gaap	Disposal Group Including Discontinued Operation Revenue DisposalGroupIncludingDiscontinuedOperationRevenue	331730750	usd
	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	21751512	usd
CY2022Q3	dcgo	Total Assets TotalAssets	355920210	usd
	us-gaap	Cost Depreciation Amortization And Depletion CostDepreciationAmortizationAndDepletion	7253656	usd
	dcgo	Stock Compensation StockCompensation	4533759	usd
CY2022Q3	us-gaap	Noncurrent Assets NoncurrentAssets	72758983	usd
	us-gaap	Disposal Group Including Discontinued Operation Revenue DisposalGroupIncludingDiscontinuedOperationRevenue	197394379	usd
	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-95984	usd
CY2021Q3	dcgo	Total Assets TotalAssets	144078865	usd
	us-gaap	Cost Depreciation Amortization And Depletion CostDepreciationAmortizationAndDepletion	5514303	usd
	dcgo	Stock Compensation StockCompensation	1224580	usd
CY2021Q3	us-gaap	Noncurrent Assets NoncurrentAssets	27894236	usd
CY2022Q2	us-gaap	Stock Repurchase Program Authorized Amount1 StockRepurchaseProgramAuthorizedAmount1	40000000	usd
CY2022Q2	us-gaap	Stock Repurchase Program Remaining Number Of Shares Authorized To Be Repurchased StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased	70000	shares
CY2022Q2	us-gaap	Stock Repurchase Program Authorized Amount1 StockRepurchaseProgramAuthorizedAmount1	498000	usd
CY2019Q2	us-gaap	Debt Instrument Maturity Date DebtInstrumentMaturityDate	2029-06-06
CY2022Q3	us-gaap	Common Stock Capital Shares Reserved For Future Issuance CommonStockCapitalSharesReservedForFutureIssuance	16607894	shares
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1	P10Y
CY2022Q3	dcgo	Share Based Compensation Arrangement By Share Based Payment Award Option Vested And Expected To Vest Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionVestedAndExpectedToVestExercisableNumber	2500000	shares
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P4Y
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.65	pure
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	8422972	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	6.21
CY2021Q4	dcgo	Weighted Average Remaining Contractual Life In Years WeightedAverageRemainingContractualLifeInYears	P8Y9M7D
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	24706020	usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	2183026	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	5.92
	dcgo	Weighted Average Remaining Contractual Life In Years Granted Vested During The Year WeightedAverageRemainingContractualLifeInYearsGrantedVestedDuringTheYear	P9Y25D
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	1637159	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	2.04
	dcgo	Weighted Average Remaining Contractual Life In Years Exercised During The Year WeightedAverageRemainingContractualLifeInYearsExercisedDuringTheYear	P5Y5M19D
	dcgo	Share Based Compensation Arrangement By Shares Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementBySharesBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	706642	shares
	dcgo	Share Based Compensation Arrangements By Share Based Payment Award Options Expiration In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationInPeriodWeightedAverageExercisePrice	7.71
	dcgo	Weighted Average Remaining Contractual Life In Years Cancelled During The Year WeightedAverageRemainingContractualLifeInYearsCancelledDuringTheYear	P8Y9M25D
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	8262197	shares
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	7.04
CY2022Q3	dcgo	Weighted Average Remaining Contractual Life In Years WeightedAverageRemainingContractualLifeInYears	P8Y8M19D
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	22950815	usd
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber	2502717	shares
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice	6.11
	dcgo	Weighted Average Remaining Contractual Life In Years Options Vested And Exercisable WeightedAverageRemainingContractualLifeInYearsOptionsVestedAndExercisable	P8Y3M18D
CY2022Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	10010617	usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	5.92
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	2.8
	dcgo	Stock Option Awards Granted StockOptionAwardsGranted	27812078	usd
CY2021	dcgo	Stock Option Awards Granted StockOptionAwardsGranted	20792804	usd
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1	P3Y8M23D
CY2021Q4	dcgo	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number Rs Us Balance ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumberRSUsBalance	50192	shares
CY2021Q4	dcgo	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Weighted Average Balance SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageBalance	9.97
	dcgo	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number Rs Us Granted ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumberRSUsGranted	146853	shares
	dcgo	Weighted Average Grant Date Fair Value Per Rsu Granted WeightedAverageGrantDateFairValuePerRSUGranted	7.15
CY2022Q3	dcgo	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number Rs Us Vested ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumberRSUsVested	-16645	shares
	dcgo	Weighted Average Grant Date Fair Value Per Rsu Vested WeightedAverageGrantDateFairValuePerRSUVested	9.97
CY2022Q3	dcgo	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number Rs Us Balance ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumberRSUsBalance	180400	shares
CY2022Q3	dcgo	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Weighted Average Balance SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageBalance	7.67
CY2022Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares	180400	shares
	dcgo	Weighted Average Grant Date Fair Value Per Rsu Nonvested WeightedAverageGrantDateFairValuePerRSUNonvested	7.67
	dcgo	Total Grantdate Fair Value TotalGrantdateFairValue	1049999	usd
	dcgo	Stockbased Compensation Expense StockbasedCompensationExpense	177840	usd
CY2022Q3	dcgo	Unrecognized Compensation Cost UnrecognizedCompensationCost	1241163	usd
	dcgo	Weightedaverage Period WeightedaveragePeriod	P3Y1M6D
CY2019Q1	us-gaap	Subordinated Borrowing Interest Rate SubordinatedBorrowingInterestRate	0.06	pure
CY2022Q3	us-gaap	Operating Lease Expense OperatingLeaseExpense	626188	usd
CY2021Q3	us-gaap	Operating Lease Expense OperatingLeaseExpense	508128	usd
	us-gaap	Operating Lease Expense OperatingLeaseExpense	1517541	usd
	us-gaap	Operating Lease Expense OperatingLeaseExpense	1446067	usd
CY2022Q3	us-gaap	Short Term Lease Cost ShortTermLeaseCost	334619	usd
CY2021Q3	us-gaap	Short Term Lease Cost ShortTermLeaseCost	62653	usd
	us-gaap	Short Term Lease Cost ShortTermLeaseCost	863316	usd
	us-gaap	Short Term Lease Cost ShortTermLeaseCost	256448	usd
CY2022Q3	us-gaap	Lease Cost LeaseCost	960807	usd
CY2021Q3	us-gaap	Lease Cost LeaseCost	570781	usd
	us-gaap	Lease Cost LeaseCost	2380857	usd
	us-gaap	Lease Cost LeaseCost	1702515	usd
CY2022Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	8185547	usd
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	4195682	usd
CY2022Q3	dcgo	Operating Lease Assets OperatingLeaseAssets	8185547	usd
CY2021Q4	dcgo	Operating Lease Assets OperatingLeaseAssets	4195682	usd
CY2022Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	2059278	usd
CY2021Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	1461335	usd
CY2022Q3	dcgo	Lease Liability Net Of Non Current Portion LeaseLiabilityNetOfNonCurrentPortion	6406246	usd
CY2021Q4	dcgo	Lease Liability Net Of Non Current Portion LeaseLiabilityNetOfNonCurrentPortion	2980946	usd
CY2022Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	8465524	usd
CY2021Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	4442281	usd
CY2022Q3	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P5Y2M19D
CY2022Q3	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.06	pure
CY2022Q3	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	960807	usd
CY2021Q3	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	570781	usd
	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	2380857	usd
	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	1702515	usd
CY2022Q3	us-gaap	Operating Lease Payments OperatingLeasePayments	626188	usd
CY2022Q3	dcgo	Financing Lease Payments FinancingLeasePayments	672975	usd
CY2021Q3	us-gaap	Operating Lease Payments OperatingLeasePayments	519716	usd
CY2021Q3	dcgo	Financing Lease Payments FinancingLeasePayments	725233	usd
	us-gaap	Operating Lease Payments OperatingLeasePayments	1517541	usd
	dcgo	Financing Lease Payments FinancingLeasePayments	2146857	usd
	us-gaap	Operating Lease Payments OperatingLeasePayments	1446067	usd
	dcgo	Financing Lease Payments FinancingLeasePayments	1972283	usd
	us-gaap	Finance Lease Interest Payment On Liability FinanceLeaseInterestPaymentOnLiability	8945489	usd
CY2021	us-gaap	Finance Lease Interest Payment On Liability FinanceLeaseInterestPaymentOnLiability	10139410	usd
CY2022Q3	dcgo	Accumulated Depreciation AccumulatedDepreciation	9662686	usd
CY2021Q4	dcgo	Accumulated Depreciation AccumulatedDepreciation	7095242	usd
CY2022Q3	dcgo	Depreciation Expenses DepreciationExpenses	873713	usd
CY2021Q3	dcgo	Depreciation Expenses DepreciationExpenses	752313	usd
	dcgo	Depreciation Expenses DepreciationExpenses	2391989	usd
	dcgo	Depreciation Expenses DepreciationExpenses	2109770	usd
	us-gaap	Other Nonoperating Gains Losses OtherNonoperatingGainsLosses	1400000	usd
CY2022Q3	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	672975	usd
CY2021Q3	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	717891	usd
	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	2146857	usd
	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	1972283	usd
CY2022Q3	us-gaap	Lease Income LeaseIncome	672975	usd
CY2021Q3	us-gaap	Lease Income LeaseIncome	717891	usd
	us-gaap	Lease Income LeaseIncome	2146857	usd
	us-gaap	Lease Income LeaseIncome	1972283	usd
CY2022Q3	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	9421196	usd
CY2021Q4	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	9307113	usd
CY2022Q3	dcgo	Finance Lease Assets FinanceLeaseAssets	9421196	usd
CY2021Q4	dcgo	Finance Lease Assets FinanceLeaseAssets	9307113	usd
CY2022Q3	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	2858968	usd
CY2021Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	3271990	usd
CY2022Q3	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	6086521	usd
CY2021Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	6867420	usd
CY2022Q3	us-gaap	Finance Lease Liability FinanceLeaseLiability	8945489	usd
CY2021Q4	us-gaap	Finance Lease Liability FinanceLeaseLiability	10139410	usd
CY2022Q3	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P3Y11M1D
CY2022Q3	us-gaap	Operating Leases Future Minimum Payments Due In Two Years OperatingLeasesFutureMinimumPaymentsDueInTwoYears	2375470	usd
CY2022Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2021Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q3	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.0601	pure
CY2022Q3	us-gaap	Operating Leases Future Minimum Payments Due Current OperatingLeasesFutureMinimumPaymentsDueCurrent	676878	usd
CY2022Q3	us-gaap	Operating Leases Future Minimum Payments Due In Three Years OperatingLeasesFutureMinimumPaymentsDueInThreeYears	1880974	usd
CY2022Q3	us-gaap	Operating Leases Future Minimum Payments Due In Four Years OperatingLeasesFutureMinimumPaymentsDueInFourYears	1897247	usd
CY2022Q3	us-gaap	Operating Leases Future Minimum Payments Due In Five Years OperatingLeasesFutureMinimumPaymentsDueInFiveYears	1499654	usd
CY2022Q3	us-gaap	Operating Leases Future Minimum Payments Due Thereafter OperatingLeasesFutureMinimumPaymentsDueThereafter	1418692	usd
CY2022Q3	us-gaap	Operating Leases Future Minimum Payments Due OperatingLeasesFutureMinimumPaymentsDue	9748915	usd
CY2022Q3	dcgo	Lessee Operating Lease Liability Discounted Excess Amount LesseeOperatingLeaseLiabilityDiscountedExcessAmount	-1283391	usd
CY2022Q3	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	8465524	usd
	us-gaap	Other Operating Income OtherOperatingIncome	1.8	usd
	us-gaap	Payments For Commissions PaymentsForCommissions	261185	usd
	us-gaap	Payments For Commissions PaymentsForCommissions	186075	usd
	us-gaap	Payments For Commissions PaymentsForCommissions	704593	usd
	us-gaap	Payments For Commissions PaymentsForCommissions	476293	usd
	us-gaap	Payments To Employees PaymentsToEmployees	118645	usd
	us-gaap	Payments To Employees PaymentsToEmployees	92359	usd
	us-gaap	Payments To Employees PaymentsToEmployees	364844	usd
	us-gaap	Payments To Employees PaymentsToEmployees	592417	usd
CY2022Q3	us-gaap	Accounts Payable Related Parties Current And Noncurrent AccountsPayableRelatedPartiesCurrentAndNoncurrent	118604	usd
CY2021Q4	us-gaap	Due To Related Parties Current And Noncurrent DueToRelatedPartiesCurrentAndNoncurrent	94636	usd
CY2022Q3	dcgo	Income Tax Expensebenefit IncomeTaxExpensebenefit	401906	usd
CY2021Q3	dcgo	Income Tax Expensebenefit IncomeTaxExpensebenefit	604608	usd
	dcgo	Income Tax Expensebenefit IncomeTaxExpensebenefit	1163755	usd
	dcgo	Income Tax Expensebenefit IncomeTaxExpensebenefit	613531	usd
CY2021Q3	us-gaap	Unrealized Gain Loss On Derivatives And Commodity Contracts UnrealizedGainLossOnDerivativesAndCommodityContracts		usd
	us-gaap	Unrealized Gain Loss On Derivatives And Commodity Contracts UnrealizedGainLossOnDerivativesAndCommodityContracts		usd
CY2021Q3	dcgo	Income Loss From Equity Methods Investments IncomeLossFromEquityMethodsInvestments		usd
CY2022Q3	us-gaap	Deferred Compensation Arrangement With Individual Recorded Liability DeferredCompensationArrangementWithIndividualRecordedLiability	1000000	usd
CY2021Q4	us-gaap	Deferred Compensation Arrangement With Individual Recorded Liability DeferredCompensationArrangementWithIndividualRecordedLiability	1000000	usd
CY2021Q2	us-gaap	Administrative Fees Expense AdministrativeFeesExpense	1000000	usd
CY2020Q2	us-gaap	Proceeds From Fees Received ProceedsFromFeesReceived	2397024	usd
	us-gaap	Long Term Debt Maturities Repayment Terms LongTermDebtMaturitiesRepaymentTerms	11 months
	dcgo	Medicare Payment Percentage MedicarePaymentPercentage	0.25	pure
	dcgo	Medicare Accelerated Payments Description MedicareAcceleratedPaymentsDescription	At the end of the eleven-month period, recoupment will increase to 50% for six months. At the end of the six months (or 29 months from the receipt of the initial accelerated payment), Medicare will issue a letter for full repayment of any remaining balance, as applicable. In such event, if payment is not received within 30 days, interest will accrue at the annual percentage rate of four percent (4%) from the date the letter was issued and will be assessed for each full 30-day period that the balance remains unpaid.
CY2021Q4	dcgo	Medicare Accelerated Payments MedicareAcceleratedPayments	975415	usd
CY2022Q3	dcgo	Medicare Accelerated Payments MedicareAcceleratedPayments	975415	usd
	us-gaap	Subsequent Event Description SubsequentEventDescription	On November 1, 2022, the Company entered into a revolving loan and security agreement with two banks, with one bank as the administrative agent (the “Lenders”), with a maximum revolving advance amount of $90,000,000. The revolving facility includes the ability for the Company to request an increase to the commitment by an additional up to $50,000,000, though no Lender (nor the Lenders collectively) are obligated to increase their respective commitments. Borrowings under the revolving facility bear interest at a per annum rate equal to, (i) at the Company’s option, the (x) the base rate or (y) the adjusted term SOFR rate, plus (ii) the applicable margin. The applicable margins are based on the Company’s consolidated net leverage ratio, adjusted on a quarterly basis. The initial applicable margins are 1.25% for an adjusted term SOFR loan and 0.25% for a base rate loan and will be updated based on the consolidated net leverage ratio reported in the compliance certificate.
	dcgo	Income Loss From Equity Methods Investments IncomeLossFromEquityMethodsInvestments		usd
CY2022Q3	us-gaap	Gain Loss On Investments GainLossOnInvestments		usd
CY2021Q3	us-gaap	Gain Loss On Investments GainLossOnInvestments		usd
	us-gaap	Gain Loss On Investments GainLossOnInvestments		usd
CY2022Q3	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt		usd
CY2021Q3	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1		usd
CY2021Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense		usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense		usd
CY2021Q1	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther		usd
CY2022Q3	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue		usd
CY2022Q3	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions		usd
	us-gaap	Gains Losses On Restructuring Of Debt GainsLossesOnRestructuringOfDebt		usd
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments		usd
	us-gaap	Gain Loss On Termination Of Lease GainLossOnTerminationOfLease		usd
	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives		usd
	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment		usd
	dcgo	Due To Seller DueToSeller		usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock		usd
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock		usd
	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts		usd
	us-gaap	Stock Issued1 StockIssued1		usd
	dcgo	Gain From Ppp Loan Forgiveness GainFromPPPLoanForgiveness		usd
CY2022Q3	dcgo	Medicare Advance MedicareAdvance		usd
CY2022Q3	us-gaap	Deposits Received For Securities Loaned At Carrying Value DepositsReceivedForSecuritiesLoanedAtCarryingValue		usd
CY2021Q4	us-gaap	Deposits Received For Securities Loaned At Carrying Value DepositsReceivedForSecuritiesLoanedAtCarryingValue		usd
	us-gaap	Product Warranty Accrual Warranties Issued ProductWarrantyAccrualWarrantiesIssued		usd
	dcgo	Aggregate Intrinsic Value Exercised During The Year AggregateIntrinsicValueExercisedDuringTheYear		usd
	dcgo	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeiture And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitureAndExpirationsInPeriod		usd
	dcgo	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number Rs Us Forfeited ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumberRSUsForfeited		shares
	dcgo	Weighted Average Grant Date Fair Value Per Rsu Forfeited WeightedAverageGrantDateFairValuePerRSUForfeited
	dcgo	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number Rs Us Vested And Unissued ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumberRSUsVestedAndUnissued		shares
	dcgo	Weighted Average Grant Date Fair Value Per Rsu Vested And Unissued WeightedAverageGrantDateFairValuePerRSUVestedAndUnissued
CY2022Q3	us-gaap	Short Term Lease Payments ShortTermLeasePayments		usd
CY2021Q3	us-gaap	Short Term Lease Payments ShortTermLeasePayments		usd
	us-gaap	Short Term Lease Payments ShortTermLeasePayments		usd
	us-gaap	Debt Conversion Original Debt Due Date Of Debt Year DebtConversionOriginalDebtDueDateOfDebtYear	2026
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Entity Central Index Key EntityCentralIndexKey	0001822359

Files In Submission

Name	View Source	Status
FilingSummary.xml	Edgar Link	unprocessable
dcgo-20220930_def.xml	Edgar Link	unprocessable
0001213900-22-070146-index-headers.html	Edgar Link	pending
0001213900-22-070146-index.html	Edgar Link	pending
0001213900-22-070146.txt	Edgar Link	pending
0001213900-22-070146-xbrl.zip	Edgar Link	pending
dcgo-20220930.xsd	Edgar Link	pending
f10q0922ex31-1_docgoinc.htm	Edgar Link	pending
f10q0922ex31-2_docgoinc.htm	Edgar Link	pending
f10q0922ex32-1_docgoinc.htm	Edgar Link	pending
dcgo-20220930_lab.xml	Edgar Link	unprocessable
dcgo-20220930_pre.xml	Edgar Link	unprocessable
dcgo-20220930_cal.xml	Edgar Link	unprocessable
f10q0922ex32-2_docgoinc.htm	Edgar Link	pending
f10q0922_docgoinc.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
f10q0922_docgoinc_htm.xml	Edgar Link	completed
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$DCGO
DocGo Inc. Stock $dcgo

2022 Q4 Form 10-Q Financial Statement

#000121390022070146 Filed on November 08, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$DCGO DocGo Inc. Stock $dcgo

2022 Q4 Form 10-Q Financial Statement

#000121390022070146 Filed on November 08, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$DCGO
DocGo Inc. Stock $dcgo